SBIR/STTR Research Award
IVD device for Patient Immune Profiling and personalized treatment selection (PIP)
Award amount
$4,100,000Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Advanced Research Projects Agency for Health
- Recipient company
- FEROMICS INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- HUABW6E34U75
- Solicitation number
- 75N91024R00006
- Topic code
- ARPA-H 4
Research abstract
Feromics has demonstrated the effectiveness of in-droplet live cell immunoassays for accurately profiling patients' immune cells. Building on this foundation, the company is advancing its proprietary Patient Immune Profiling (PIP) platform, paired with advanced imaging and powerful AI tools, to develop and validate a cutting-edge IVD point-of-care device. This technology will support clinicians in predicting patient responses to immunotherapy and provide critical insights into immune cell diversity, driving personalized medicine forward and improving immunotherapy outcomes.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.